| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/18/2013 | US20130095051 Avermectin/metronidazole compositions for treating afflictions of the skin, e.g., rosacea |
| 04/18/2013 | US20130095049 Antioxidant composition |
| 04/18/2013 | US20130095044 Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract |
| 04/18/2013 | US20130095032 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 04/18/2013 | DE19780440B3 Insektizidkombination gegen Läuse von Säugern, insbesondere von Hunden und Katzen Insecticide combination against lice of mammals, especially dogs and cats |
| 04/18/2013 | CA2852064A1 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof |
| 04/18/2013 | CA2852063A1 Phytoglycogen-based compositions, materials and methods |
| 04/18/2013 | CA2852060A1 Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions containing them |
| 04/18/2013 | CA2852058A1 Solid dispersion |
| 04/18/2013 | CA2852057A1 3,3-disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
| 04/18/2013 | CA2852055A1 Dietary supplements with rapid buccal dissolution |
| 04/18/2013 | CA2851970A1 Tricyclo-phosphorothioate dna |
| 04/18/2013 | CA2851838A1 Compositions and methods for treating and preventing coronary heart disease |
| 04/18/2013 | CA2851810A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 04/18/2013 | CA2851788A1 Pyrazol-3-ones that activate pro-apoptotic bax |
| 04/18/2013 | CA2851780A1 Methods of treating pediatric patients using dexmedetomidine |
| 04/18/2013 | CA2851764A1 Compositions comprising salbutamol sulphate |
| 04/18/2013 | CA2851761A1 Method of diagnosis, prognostic or treatment of neurodegenerative diseases |
| 04/18/2013 | CA2851751A1 Compositions for the treatment of rheumatoid arthritis and methods of using same |
| 04/18/2013 | CA2851741A1 Derivative of butylphthalide and preparation method and use thereof |
| 04/18/2013 | CA2851623A1 5,7-substituted-imidazo[1,2-c]pyrimidines |
| 04/18/2013 | CA2851619A1 The use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic pain |
| 04/18/2013 | CA2851614A1 Compositions useful in treating nephropathy and methods for preparation of same |
| 04/18/2013 | CA2851588A1 Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy)-1h-quinolin-2-one or a salt thereof |
| 04/18/2013 | CA2851579A1 Accelerating muscle recovery after immobilization-induced muscle atrophy |
| 04/18/2013 | CA2851576A1 Method for preparing glucans from aspergillus niger |
| 04/18/2013 | CA2851525A1 Treatment of multiple sclerosis with combination of laquinimod and fingolimod |
| 04/18/2013 | CA2851522A1 Buffered oxygen therapeutic |
| 04/18/2013 | CA2851516A1 Guanidinyl-substituted polyamides useful for treating human papilloma virus |
| 04/18/2013 | CA2851513A1 Method for treating acute kidney injury |
| 04/18/2013 | CA2851445A1 Novel oxazine derivatives and their use in the treatment of disease |
| 04/18/2013 | CA2851433A1 R(+)-n-methyl-propargyl-aminoindan |
| 04/18/2013 | CA2851383A1 2 - carboxamide cycloamino urea derivatives in combination with hsp90 inhibitors for the treatment of proliferative diseases |
| 04/18/2013 | CA2851364A1 8-carbamoyl-2-(2,3-di substituted pyrid-6-yl)-1,2,3,4-tetrahydroisoquinoline derivatives as apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 04/18/2013 | CA2851276A1 R(+)-n-formyl-propargyl-aminoindan |
| 04/18/2013 | CA2851274A1 Rasagiline citramide |
| 04/18/2013 | CA2851218A1 Polycyclic pyridone derivative having integrase-inhibiting activity |
| 04/18/2013 | CA2851180A1 Method and compositions for treating skin |
| 04/18/2013 | CA2851179A1 A process for making an intermediate of cabazitaxel |
| 04/18/2013 | CA2851155A1 Heterocyclic compounds and methods of use thereof |
| 04/18/2013 | CA2851087A1 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases |
| 04/18/2013 | CA2851026A1 Compositions comprising salbutamol sulphate |
| 04/18/2013 | CA2850836A1 Methods of using scd1 antagonists |
| 04/18/2013 | CA2850707A1 Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
| 04/18/2013 | CA2850439A1 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and use as antiviral agents |
| 04/18/2013 | CA2850394A1 Indazole compounds as kinase inhibitors and method of treating cancer with same |
| 04/18/2013 | CA2850373A1 Pyrrolobenzodiazepines and targeted conjugates |
| 04/18/2013 | CA2850264A1 Pyrrolobenzodiazepines |
| 04/18/2013 | CA2850103A1 Pyrrolobenzodiazepines |
| 04/18/2013 | CA2850096A1 Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines |
| 04/18/2013 | CA2849385A1 2-oxo-piperidinyl derivatives |
| 04/18/2013 | CA2849331A1 Treatment of pharmacological-induced hypochlorhydria |
| 04/18/2013 | CA2849192A1 Prevention and treatment of ocular conditions |
| 04/18/2013 | CA2848197A1 Protein kinase inhibitors |
| 04/18/2013 | CA2847889A1 Selective androgen receptor modulators |
| 04/18/2013 | CA2847083A1 Antiviral compounds |
| 04/18/2013 | CA2847071A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease |
| 04/18/2013 | CA2845939A1 Fluorescent dyes |
| 04/17/2013 | EP2581451A1 Compounds for inhibiting mammalian s-nitrosoglutathione reductase |
| 04/17/2013 | EP2581449A2 Novel genes related to glutaminyl cyclase |
| 04/17/2013 | EP2581448A1 Tricyclo-phosphorothioate DNA |
| 04/17/2013 | EP2581442A1 Process for production of hematopoietic stem cell |
| 04/17/2013 | EP2581380A1 Sialic acid ( -(2 6)-d-aminopyranose derivatives, synthesis methods and uses thereof |
| 04/17/2013 | EP2581376A1 Matrinic acid/ matrine derivatives and preparation methods and uses thereof |
| 04/17/2013 | EP2581375A2 Improved methods for the preparation of quinoxaline derivatives |
| 04/17/2013 | EP2581374A1 Preparation of tetrahydropyrido[4,3-b]indole derivatives |
| 04/17/2013 | EP2581373A1 Benzo- or pyrido-imidazole derivative |
| 04/17/2013 | EP2581372A1 Cyanoquinoline derivatives |
| 04/17/2013 | EP2581371A1 Pyrrolyl substituted dihydroindol-2-one derivatives, preparation methods and uses thereof |
| 04/17/2013 | EP2581370A1 Crystals of di(arylamino)aryl compound |
| 04/17/2013 | EP2581369A1 Preparation process of dronedarone and its salts |
| 04/17/2013 | EP2581367A2 Salts of isophosphoramide mustard and analogs thereof |
| 04/17/2013 | EP2581366A1 Renin Inhibitors |
| 04/17/2013 | EP2581090A1 Glycosaminoglycan oral use and compositions |
| 04/17/2013 | EP2581089A1 Manufacturing method for polyphenol composition |
| 04/17/2013 | EP2581088A1 New use of icariin and epimedium flavonoids containing icariin |
| 04/17/2013 | EP2581087A1 Composition containing iridoids and uses thereof |
| 04/17/2013 | EP2581086A2 Composition for preventing or treating osteoporosis, and manufacturing method therefor |
| 04/17/2013 | EP2581085A1 Pharmaceutical composition for nasal administration of metopimazine |
| 04/17/2013 | EP2581084A1 Solid dispersion comprising triazole compound |
| 04/17/2013 | EP2581083A1 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents |
| 04/17/2013 | EP2581082A1 Pharmaceutical compound for treating status asthmaticus |
| 04/17/2013 | EP2581081A2 Treatment of viral infections by modulation of host cell metabolic pathways |
| 04/17/2013 | EP2581080A1 Inhibitor of colonisation of mucosa |
| 04/17/2013 | EP2581079A1 Combination of hyaluronic acid and prilocaine |
| 04/17/2013 | EP2581078A1 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| 04/17/2013 | EP2580967A1 Accelerating muscle recovery after immobilization-induced muscle atrophy |
| 04/17/2013 | EP2580328A2 Micrornas for the detection and isolaton of human embryonic stem cell-derived cardiac cell types |
| 04/17/2013 | EP2580324A2 Methods for the development of vaccines based on oligosaccharide-oligonucleotide conjugates |
| 04/17/2013 | EP2580225A1 Crystalline form of benzylbenzene sglt2 inhibitor |
| 04/17/2013 | EP2580221A1 Crystalline forms of kinase inhibitors |
| 04/17/2013 | EP2580220A1 Crystalline forms of kinase inhibitors |
| 04/17/2013 | EP2580219A1 Crystalline forms of kinase inhibitors |
| 04/17/2013 | EP2580217A2 6-(ethynyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/17/2013 | EP2580216A2 8-(sulfonylbenzyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/17/2013 | EP2580215A2 8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/17/2013 | EP2580214A2 6-(sulfonylaryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/17/2013 | EP2580213A2 8-(HETEROARYLMETHYL)PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS |
| 04/17/2013 | EP2580212A1 Urea derivatives and their therapeutic use in the treatment of, inter alia, diseases of the respiratory tract |
| 04/17/2013 | EP2580210A2 Estrogen receptor modulators and uses thereof |